Cited by 108Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsDiet, Metabolism, and Disease

Favourable metabolic effects of a eucaloric lower‐carbohydrate diet in women with PCOS

Open access
Gower, Barbara A., Chandler‐Laney, Paula C., Ovalle, Fernando, Goree, Laura Lee, Azziz, Ricardo, Desmond, Renee A., Granger, Wesley M., Goss, Amy M. +1 more·2013·Clinical Endocrinology

Abstract

Summary: Objective: Diet‐induced reduction in circulating insulin may be an attractive nonpharmacological treatment for women with polycystic ovary syndrome (PCOS) among whom elevated insulin may exacerbate symptoms by stimulating testosterone synthesis. This study was designed to determine whether a modest reduction in dietary carbohydrate (CHO) content affects β‐cell responsiveness, serum testosterone concentration and insulin sensitivity in women with PCOS. Design: In a crossover design, two diets (‘Standard,’ STD, 55:18:27% energy from carbohydrate/protein/fat; lower‐carbohydrate, 41:19:40) were provided for 8 weeks in random order with a 4‐week washout between. Patients: Thirty women with PCOS. Measurements: β‐cell responsiveness assessed as the C‐peptide response to glucose during a liquid meal test; insulin sensitivity from insulin and glucose values throughout the test; insulin resistance (HOMA‐IR); and total testosterone by immunoassay. Results: Paired t‐test indicated that the lower‐CHO diet induced significant decreases in basal β‐cell response (PhiB), fasting insulin, fasting glucose, HOMA‐IR, total testosterone and all cholesterol measures, and significant increases in insulin sensitivity and dynamic (‘first‐phase’) β‐cell response. The STD diet induced a decrease in HDL‐C and an increase in the total cholesterol‐to‐HDL‐C ratio. Across all data combined, the change in testosterone was positively associated with the changes in fasting insulin, PhiB and insulin AUC (P < 0·05). Conclusions: In women with PCOS, modest reduction in dietary CHO in the context of a weight‐maintaining diet has numerous beneficial effects on the metabolic profile that may lead to a decrease in circulating testosterone.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cen.12175

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gower, B. A., Chandler‐Laney, P. C., Ovalle, F., Goree, L. L., Azziz, R., Desmond, R. A., Granger, W. M., Goss, A. M., & Bates, G. W.
Affiliations
  • University of Alabama at Birmingham (US)
  • Department of Nutrition Sciences University of Alabama at Birmingham Birmingham AL USA
  • Department of Medicine Georgia Health Sciences University Augusta GA USA
  • Department of Medicine Division of Preventive Medicine University of Alabama at Birmingham Birmingham AL USA
Corresponding author
Gower, Barbara A.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2013-05-20
Volume
79
Issue
4
Pages
550-557
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2101105380
Cited by
108
References
40
Citations by year
2026: 3 · 2025: 7 · 2024: 8 · 2023: 15 · 2022: 14 · 2021: 12 · 2020: 17 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 5 · 2015: 6 · 2014: 5
FWCI
6.46
Type
journal article
Language
en
Open access
Locations
  • Clinical Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • University of Alabama at Birmingham
  • National Institutes of Health (5ul1rr025777-04, 5p60dk079626-05)
  • Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston
  • Center for Clinical and Translational Science, University of Alabama at Birmingham
  • National Institute of Diabetes and Digestive and Kidney Diseases (P60-DK-079626, T32DK062710, P30DK056336, P30DK079626)
  • National Center for Research Resources (UL1-RR-025777)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD054960)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
polycystic ovary syndrome, low-carbohydrate diet, insulin sensitivity, insulin resistance, beta-cell function, first-phase insulin response, testosterone, insulin resistance index, cholesterol, HDL cholesterol, non-pharmacological treatment
MeSH terms
Adult, Blood Glucose, Dietary Carbohydrates, Fasting, Female, Humans, Insulin, Insulin Resistance, Lipids, Middle Aged, Polycystic Ovary Syndrome, Testosterone, Outcome Assessment, Health Care, Cross-Over Studies, Insulin-Secreting Cells, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review